Hepatic artery thrombosis (HAT) can result in biliary tree necrosis and graft loss, necessitating retransplantation. The most effective treatment approach is still controversial. This study was performed to review the outcomes of HAT after living donor liver transplantation (LDLT) and to clarify the feasibility of different strategies. From May 1996 to August 2017, LDLT using the right lobe was performed in 827 adult patients in our center. Our technique of hepatic artery (HA) reconstruction is endto-end anastomosis under a microscope (10×). Diagnosis of HAT was performed using Doppler sonography and computed tomography (CT) angiography. HAT was initially treated with surgical or endovascular procedure, and retransplantation was considered according to the graft condition. Among the 827 cases of LDLT using the right lobe, HAT occurred in 16 (1.9%) cases within 1 month after transplantation. Within the first week, 7 of these HAT cases (43.8%) occurred (early HAT), while the remaining 9 cases (56.2%) occurred between the first week and 1 month (late HAT). The incidence of graft failure was high in early HAT (42.9%), and the frequency of biliary complications was high in late HAT (77.8%). The success rate of HA recanalization was 62.5% (10/16): 100% (5/5) after reoperation and 45.5% (5/11) after the endovascular procedure. Of the patients in whom treatment failed in late HAT (n = 5), 4 underwent neovascularization during observation. A total of 5 patients underwent graft failure, and 3 of these patients underwent repeat liver transplantation (LT). Mortality occurred in 3 patients, including 1 in the surgical group and 2 in the endovascular group. In conclusion, early diagnosis and aggressive treatment of HAT are necessary to avoid graft failure, and the choice of treatment depends on various factors. Although further studies are required, early HAT requires preparation for graft failure, while late HAT requires treatment for biliary complications.
Introduction
Liver transplantation (LT) has been established as the treatment of choice for end-stage liver disease and unresectable hepatocellular carcinoma (HCC). In recent years, the rate of living donor liver transplantation (LDLT) has increased due to the lack of donors. (1, 2) However, arterial anastomosis in LDLT is more technically difficult than deceased donor LT.
After LT, the only arterial flow to the graft liver is through hepatic artery (HA) anastomosis. Hepatic artery thrombosis (HAT) is one of the most severe complications after LDLT, and it may lead to graft loss and death of the transplant recipient. (3, 4) HAT is the most common vascular complication of LDLT, with estimated incidence rates ranging from 2.5% to 11%. (5, 6) Furthermore, HAT remains one of the major causes of graft failure and transplant recipient mortality. Therefore, early diagnosis and revascularization are necessary to avoid these consequences.
There is still controversy regarding the most effective treatment approach between surgical revascularization and endovascular management. Surgical revascularization is an effective treatment for graft salvage, and chOi et al.
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it may help as a bridge toward retransplantation in a less emergent setting. (7) (8) (9) Endovascular procedures, including intra-arterial thrombolysis, balloon angioplasty, and stent placement, have been suggested as alternatives to open surgical repair. (10, 11) This study was performed to review the outcomes of HAT after LDLT and to clarify the feasibility of different strategies for clinical management. We reviewed 16 cases (1.9%) of postoperative HAT after LDLT using the right lobe among 827 consecutive cases of LDLT.
Patients and Methods

patients
A total of 835 patients underwent LDLT at our institution between May 1996 and August 2017. After excluding 8 pediatric LT patients treated using left lobe grafts, we reviewed 827 adult cases of LDLT using the right lobe. With the exception of 1 patient who showed HAT after cardiopulmonary resuscitation due to cardiac arrest on postoperative day (POD) 1, we reviewed 16 patients (1.9%) with HAT among the 827 total patients. The institutional review board of our center approved the study design.
Operative prOceDUre
LDLT was performed with a standard technique, using the modified right lobe with middle hepatic vein reconstruction. In HA reconstruction, the graft right hepatic artery (RHA) was connected to the recipient's RHA, left hepatic artery (LHA), or proper HA according to the diameter, length, and status of the intima. End-to-end anastomosis was performed with interrupted sutures using nylon #9-0 under a microscope (10×). For prophylaxis of vascular thrombosis, heparin was not used during or after surgery and patients did not receive aspirin or antiplatelet agents for HAT prophylaxis. A 250-µg dose of prostaglandin E1 (alprostadil) was mixed with 250 mL of 5% dextrose water and infused intravenously for 24 hours continuously at a rate of 10 mL per hour, until 6 days after LDLT. Antithrombin-III was intravenously injected 500 IU 3 times per day for 3 days after LDLT.
DiagnOsis anD treatMent OF hat
Doppler ultrasonography (US) was performed once every 2 days until the first week after the operation, and angio computed tomography (CT) was performed 1 week after surgery for routine examination of vascular status. Doppler US was performed again 2 weeks after surgery, and angio CT was performed again 3 weeks after surgery. If laboratory tests showed abnormal liver function, Doppler US or angio CT was performed to evaluate vascular complications.
Reoperations were performed mainly within 7 days after transplantation, and endovascular procedures were performed mainly for HAT occurring after 1 week. During surgery, reanastomosis was performed on the original vessel, opposite vessel, or gastroepiploic artery according to the vascular condition. Endovascular procedures were mainly performed with thrombolysis and/or a stent using urokinase (Fig. 1) .
We divided 16 HAT patients into early and late groups according to the time of onset. The early group (n = 7, 43.8%) was defined as HAT occurring within 1 week after LDLT, while the late group (n = 9, 56.2%) was defined as HAT occurring 1 week or later after LDLT. Thereafter, we reviewed the treatment results according to the timing of HAT and the success or failure of the initial treatment.
Results
DeMOgraphics OF the 16 hat patients
Among 827 cases of LDLT using the right lobe, there were 16 (1.9%) cases of HAT within 1 month after transplantation. The mean age of these 16 patients was 48.9 ± 12.8 years, and 9 of them (56.3%) were male. The mean body mass index (BMI) was 25.4 ± 4.3, and the most common cause of liver disease was hepatitis B virus (HBV) (68.8%). The mean Child score and Model for End-Stage Liver Disease (MELD) score was 8.1 ± 2.3 and 12.1 ± 7.8, respectively. A total of 9 patients (56.3%) had HCC, and 3 patients underwent transarterial chemoembolization (TACE) before LDLT. The mean MELD score of the HCC patients was 8.4 ± 5.6, and the mean MELD score of the patients without HCC was 16.9 ± 8.1. There were 3 patients (18.8%) with diabetes mellitus and 2 (12.5%) with hypertension. The mean graft volume/recipient body weight ratio (GRWR) was 1.1% ± 0.3%, and the average diameter of the graft artery was 1.8 ± 0.8 mm. Nine cases (56.3%) were connected to the RHA, 6 (37.5%) were connected to the LHA, and 1 case (6.2%) was connected to the proper HA. HAT was diagnosed at a mean of 9.2 ± 8.5 days postoperatively. For reference, the clinical characteristics of patients without HAT can be seen on the second column (Table 1) .
hat treatMent OUtcOMe
We analyzed patients according to the timing of HAT occurrence. HAT occurred within 1 week in the early HAT group (n = 7, 43.8%), and in the late HAT group (n = 9, 56.2%), HAT occurred after 1 week. Of the patients in the early HAT group, 4 underwent surgical treatment and 3 (18.8%) underwent endovascular procedures. All of the 4 patients treated surgically showed successful recanalization, but 1 progressed to graft failure. Of the remaining 3 patients with endovascular treatment, 2 underwent recanalization. One of the 2 Original article | 1557 successful patients and 1 failed patient progressed to graft failure, and both patients underwent retransplantation. In the late HAT group, 8 patients (88.9%) received endovascular treatment, and only 3 (37.5%) achieved recanalization. Among the cases of recanalization failure, 2 patients progressed to graft failure; 1 died of sepsis and the other gradually progressed to graft failure and underwent retransplantation. Only 1 (11.1%) patient received surgical treatment, and recanalization was successful (Table 2) . With regard to the treatment of HAT, 5 patients (31.3%) underwent surgical procedures using the initial artery (n = 3), opposite HA (n = 1), and transposition of the gastroepiploic artery (n = 1). The endovascular procedure was performed initially in 11 patients (68.7%). The initial treatment modality was mainly surgery in the early HAT group and endovascular treatment in the late HAT group. The success rate of HA recanalization was 100% (5/5) after reoperation, and the success rate of endovascular treatment was 45.5% (5/11). The success rate of recanalization was higher in the early HAT group than in the late HAT group (85.7% versus 44.4% respectively), but the frequency of graft failure (42.9%) was higher in the early HAT group. On the other hand, the incidence of biliary complications (77.8%) was higher in the late HAT group. The prognosis of patients was then analyzed according to the success or failure of the initial treatment. Successful initial treatment was defined as recanalization of arterial flow after treatment. The initial treatment was successful in 10 cases (62.5%) and unsuccessful in 6 cases (37.5%). In the early HAT group, graft failure occurred in 2 (33.3%) cases even after recanalization succeeded. However, in the late HAT group, graft failure did not progress if recanalization succeeded. In the cases of recanalization failure, re-LT was required for early HAT, but graft failure did not occur in 3 patients (60%) in the late HAT group due to neovascularization. After initial treatment, patients with biliary complications were treated with percutaneous transhepatic biliary drainage (PTBD) or endoscopic biliary stents. Graft failure occurred in 5 patients (31.3%). Retransplantation was performed in 3 of these patients, while the remaining 2 patients received conservative care. Both of the patients with conservative treatment eventually died. Overall, 3 patients died (18.8%), including 1 patient in the surgical procedure group and 2 patients in the endovascular procedure group. Causes of death were sepsis with graft failure (n = 2) in patients receiving conservative treatment and asphyxia with good graft function (n = 1) in the retransplantation patient.
revieW OF initial treatMent FailUre
Next, 6 patients with recanalization failure were evaluated for prognosis according to the timing of HAT (Table 3 ). In the early HAT group, 1 patient progressed to graft failure immediately and underwent retransplantation. In the late HAT group, recanalization failure occurred in 5 patients, 4 (80%) of whom obtained arterial supply through neovascularization during follow-up. Neovascularization occurred in 1 patient at 3 months, 1 patient at 5 months, and 2 patients at 6 months. All 4 patients with neovascularization developed biliary complications and were managed with PTBD or endoscopic retrograde biliary drainage (ERBD). One of these patients progressed gradually to graft failure and underwent retransplantation at 13 months. Serial alanine aminotransferase (ALT) and bilirubin levels were checked to examine changes in liver function in patients with initial treatment failure according to neovascularization. Changes in ALT did not appear to be significant before or after neovascularization. Three patients showed a decrease in total bilirubin at the time of neovascularization, but 1 patient continued to have elevated total bilirubin and progressed to hepatic failure. The remaining patient with initial treatment failure died of graft failure and sepsis at 96 days after transplantation without neovascularization (Fig. 2) .
Discussion
In LDLT, reconstruction of the HA is difficult because the graft HA (1.8 ± 0.8 mm in diameter) is too fine to reconstruct even using surgical loupes. However, the introduction of microsurgical techniques has made reconstruction of the HA more convenient and has resulted in a marked decrease in the incidence of HA complications. In our series, all HAs were reconstructed using microsurgical techniques regardless of size. Technical errors are the most common etiologies of HAT. One of the most frequently encountered difficulties in anastomosing HA was HA diameter discrepancy. The recipient's HA was usually thickened compared with that of the donor. The relatively high flow into the HA resulting from liver cirrhosis and portal hypertension is the leading cause of thickened HA. Gentle dilatation of HA and/or oblique cutting of the smaller side to ensure a larger diameter was attempted. Our incidence of HAT in LDLT with a relatively small HA diameter was lower than in previous studies that included many DDLT patients. (5, 6) Most previous reports on HAT focused on DDLT, and there have been few reports regarding LDLT alone. The HA plays a vital role after LT, providing blood supply for both the liver parenchyma and bile duct system. Ischemic cholangitis that severely impacts graft survival is the most common complication seen Original article | 1559 when these strictures progress toward complete HAT. Surgical revision has been widely applied to treat HA occlusion, but endovascular procedures have been applied as alternative therapeutic options in many recent cases. There is no definite criterion for selecting a surgical or endovascular procedure to treat HAT. In general, HAT is generated by the surgical factor in the immediate postoperative state, so the surgical procedure is preferred. The ease of reoperation was aided by the clear operative field due to no adhesions. However, in the late phase, HAT is thought to be due to other factors as well as the surgical factor. In addition, because the hepatic artery of the graft side is short and the diameter is small due to LDLT characteristics, reoperation is difficult when there are adhesions. Therefore, an endovascular procedure is preferred in these cases. Thus, in our cases, the percentage of surgical procedures was higher in patients developing HAT within 1 week of transplantation. In addition, recanalization was successful in all cases treated with surgery.
In the early HAT group, however, re-LT was required if recanalization failed. Therefore, surgical procedures for recanalization should be considered in cases of early HAT. In addition, preparations for graft failure should be made in patients with early HAT, even if recanalization is successful. In the late HAT group, even if recanalization failed, graft function was maintained in some patients and neovascularization eventually occurred. However, because of the high incidence of biliary complications in these patients, active treatment of biliary complications is needed to ensure the best supportive care. Questions have been raised regarding whether neovascularization occurs in the graft liver in some cases. Hepaticojejunostomy was reported to be associated with neovascularization, (12) but all of our cases had duct-to-duct anastomosis. In late HAT, HA flow was restored through neovascularization in 4 of 5 patients with recanalization failure. Three of these patients did not require re-LT. Although it is unclear which patient will progress to graft failure, it is important to observe total bilirubin progression. Bile ducts are supplied by the HA only, and the biliary epithelium is more sensitive to ischemic injury than hepatocytes. Ischemia resulting from diseases affecting the HA initially affects the bile ducts, which may lead to biliary necrosis, cast formation, abscesses, nonanastomotic bile leakage, and biloma. Therefore, actively addressing duct complications may be important to avoid graft failure because duct complications occur in all patients with recanalization failure and serial monitoring of serum bilirubin levels is important. Further studies are required to determine the pathogenesis of neovascularization in patients with failed recanalization.
Of the 16 HAT patients, 3 of them died (2 in the early HAT group and 1 in the late group), and all had graft failure. One patient died in the successful initial treatment group, and 2 patients died in the failed group. The early HAT group seemed to require more active recanalization because of the high frequency of progression to graft failure. As the recanalization rate of surgical treatment in our study was 100%, surgical intervention should be actively considered as first-line treatment. It may be possible to save the graft in the late HAT group through optimal supportive care, even if recanalization by initial treatment fails. In the present study, 4 of the recanalization failures in the late HAT group showed neovascularization, and only 1 developed graft failure. Serial changes in total bilirubin were associated with graft failure. Due to the high incidence of biliary complications in these patients, active treatment of biliary complications is needed. However, re-LT is an important treatment modality for graft failure because graft failure eventually leads to mortality.
This study had several limitations. First, the study population consisted of only a small number of patients; thus, this should be considered a preliminary study, in which it was difficult to perform statistical analyses or reach definitive conclusions. In addition, this was a retrospective study, so we did not conduct any specific molecular neoangiogenetic analyses.
In conclusion, an early diagnosis of HAT is important and follow-up is necessary after meticulous surgery. Recanalization should be performed through active surgery during the early period after LT, and retransplantation should be considered if necessary for graft failure even after successful recanalization. Endovascular treatment should be considered during the late period after LDLT due to the difficulty of the surgical treatment, and intervention should be used to treat biliary complications. Neovascularization is expected through active conservative treatment even if HAT recanalization fails. This study provides preliminary results, so further study is needed.
